Razumab both safe and cost-effective for managing retinopathy by prematurity
India: A study published in the Indian Journal of Ophthalmology has concluded that Razumab may be safely used in managing ROP by retina physicians globally. They confirmed it to be safe and cost-effective. They also added that more data will be available to corroborate findings when the use becomes widespread. In this study entitled, “Efficacy […] More